Safra Catz - Mar 25, 2024 Form 4 Insider Report for ORACLE CORP (ORCL)

Role
Chief Executive Officer, Director
Signature
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Safra Catz (POA Filed 03-21-19)
Stock symbol
ORCL
Transactions as of
Mar 25, 2024
Transactions value $
-$236,267,481
Form type
4
Date filed
3/27/2024, 07:02 PM
Previous filing
Jan 2, 2024
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $38.1M +941K +84.12% $40.47 2.06M Mar 25, 2024 Direct
transaction ORCL Common Stock Options Exercise $8.13M +209K +10.15% $38.89 2.27M Mar 25, 2024 Direct
transaction ORCL Common Stock Sale -$137M -1.09M -47.91% $126.49 1.18M Mar 25, 2024 Direct F1, F2
transaction ORCL Common Stock Sale -$8.02M -63K -5.33% $127.20 1.12M Mar 25, 2024 Direct F1, F3
transaction ORCL Common Stock Options Exercise $20.2M +500K +44.7% $40.47 1.62M Mar 26, 2024 Direct
transaction ORCL Common Stock Options Exercise $11.3M +290K +17.92% $38.89 1.91M Mar 26, 2024 Direct
transaction ORCL Common Stock Sale -$100M -790K -41.39% $126.54 1.12M Mar 26, 2024 Direct F1, F4
transaction ORCL Common Stock Options Exercise $32.7M +809K +72.32% $40.47 1.93M Mar 27, 2024 Direct
transaction ORCL Common Stock Options Exercise $38.9K +1K +0.05% $38.89 1.93M Mar 27, 2024 Direct
transaction ORCL Common Stock Sale -$94.3M -754K -39.12% $124.97 1.17M Mar 27, 2024 Direct F1, F5
transaction ORCL Common Stock Sale -$5.67M -45K -3.83% $126.02 1.13M Mar 27, 2024 Direct F1, F6
transaction ORCL Common Stock Sale -$1.35M -10.6K -0.94% $126.71 1.12M Mar 27, 2024 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -941K -41.82% $0.00 1.31M Mar 25, 2024 Common Stock 941K $40.47 Direct F8
transaction ORCL Stock Option Options Exercise $0 -209K -41.8% $0.00 291K Mar 25, 2024 Common Stock 209K $38.89 Direct F8
transaction ORCL Stock Option Options Exercise $0 -500K -38.2% $0.00 809K Mar 26, 2024 Common Stock 500K $40.47 Direct F8
transaction ORCL Stock Option Options Exercise $0 -290K -99.66% $0.00 1K Mar 26, 2024 Common Stock 290K $38.89 Direct F8
transaction ORCL Stock Option Options Exercise $0 -809K -100% $0.00* 0 Mar 27, 2024 Common Stock 809K $40.47 Direct F8
transaction ORCL Stock Option Options Exercise $0 -1K -100% $0.00* 0 Mar 27, 2024 Common Stock 1K $38.89 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to Rule 10b5-1 Plan adopted on August 1, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $126.05 to $127.05. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $127.055 to $127.45. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $126.00 to $126.935. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $124.4729 to $125.47. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $125.475 to $126.46. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $126.495 to $127.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F8 25% of the shares subject to the option vested annually on each anniversary of the grant date.